VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CBIO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CBIOCrescent Biopharma, Inc.
$17.03$470M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCBIOPrice History

CBIO logoCrescent Biopharma, Inc. (CBIO) Stock Price History

Historical prices from 2014 to 2026

$17.03+0.07  (+0.41%)close Jul 7
Returns
1M
-1.4%
3M
-11.3%
YTD
+53.7%
1Y
+11.4%
3Y
-53.3%
5Y
-39.6%
ATH$2,605.00Feb 2018-99.3%
ATL$8.72Feb 2026pre-split
Avg Vol (50D)262K/ day
52-Week Range$8.72 — $27.41
LowCurrent: $17.03High

Loading 10-year price history...

CBIO Historical Performance

1 YearTotal Return
+11.4%
Price: +11.4%
3 YearsTotal Return
-89.8%
CAGR: -53.3%
Price: -89.8%
5 YearsTotal Return
-92.0%
CAGR: -39.6%
Price: -92.0%
YTD
+53.7%

CBIO Annual Returns

Year-by-year price performance · 2014–2026

Best+167.8%2017
Worst-90.8%2024
Up years4/13
2014-20.1%
2015-23.1%
2016+3.9%
2017+167.8%
2018-44.6%
2019-47.2%
2020-27.4%
2021-61.4%
2022+91.8%
2023-18.9%
2024-90.8%
2025-53.5%
2026+9.1%
2014 annual price return
-20.1%
2015 annual price return
-23.1%
2016 annual price return
+3.9%
2017 annual price return
+167.8%
2018 annual price return
-44.6%
2019 annual price return
-47.2%
2020 annual price return
-27.4%
2021 annual price return
-61.4%
2022 annual price return
+91.8%
2023 annual price return
-18.9%
2024 annual price return
-90.8%
2025 annual price return
-53.5%
2026 annual price return
+9.1%
LessMore
Alpha vs S&P 500
1Y-5.6%
3Y-73.9%
5Y-52.0%

Price returns only.

Download Historical Data

3,140 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

CBIO Stock Price Trajectory (2014–2026)

As of July 8, 2026, Crescent Biopharma, Inc. (CBIO) trades at $17.03, representing a +11.4% return over the past year. The stock has delivered a -92.0% total return over five years (-39.6% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $2,605.00 on February 15, 2018. From this peak, CBIO has corrected -99.3%, currently trading 17% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers RCUS (+268.0% 1Y), IMVT (+144.2% 1Y), and KYMR (+172.2% 1Y), CBIO has underperformed the peer group average. Compare CBIO vs RCUS →

CBIO Historical Price Data · from 2014

Rows 1–50 of 3,140
Date Open High Low Close Volume Change %
2026-07-0716.8917.3816.5517.03223K+0.41%
2026-07-0616.8917.5816.5716.96199K-0.76%
2026-07-0217.0017.9116.5017.09260K+0.06%
2026-07-0117.9118.5216.9717.08175K-5.11%
2026-06-3018.0018.4817.5718.00265K0.00%
2026-06-2918.3218.5117.9618.00430K-1.42%
2026-06-2617.0618.7617.0518.26351K+7.47%
2026-06-2517.3918.2316.6916.99167K-2.13%
2026-06-2417.4117.8016.9217.36176K-0.80%
2026-06-2317.0218.1616.8017.50225K-0.40%
2026-06-2218.2618.7317.5017.57305K-0.68%
2026-06-1818.0618.3917.3017.69108K-2.86%
2026-06-1717.7518.7717.7518.21382K+1.45%
2026-06-1618.1518.2017.2117.95121K-1.32%
2026-06-1517.8318.3417.5018.19168K+1.51%
2026-06-1218.4119.0517.8417.92176K-2.29%
2026-06-1117.6219.0417.0518.34137K+4.38%
2026-06-1018.0918.7517.2117.57168K-2.39%
2026-06-0917.3818.2317.2518.00126K+4.17%
2026-06-0818.2718.3417.1717.28238K-4.00%
2026-06-0518.6019.0017.4718.00191K-2.44%
2026-06-0417.9018.8717.5218.45157K+2.61%
2026-06-0317.1317.9816.9117.98145K+5.73%
2026-06-0219.7719.7716.6317.00431K-13.77%
2026-06-0119.5920.4318.9419.72422K-4.50%
2026-05-2921.4022.2920.3520.65359K-3.82%
2026-05-2820.7022.4920.3521.47401K+3.27%
2026-05-2720.2522.2819.9120.79446K+2.16%
2026-05-2620.6521.1419.9320.35325K-1.88%
2026-05-2220.0021.2419.8920.74139K+2.52%
2026-05-2118.7020.5918.7020.23243K+6.98%
2026-05-2018.5119.7918.4018.91107K+2.33%
2026-05-1918.5019.1718.2218.48128K-0.38%
2026-05-1819.6220.8117.4818.55416K-7.11%
2026-05-1521.0021.6918.5119.97258K-5.93%
2026-05-1419.4121.4719.4121.23168K+8.26%
2026-05-1318.2520.4117.9319.61252K+6.23%
2026-05-1218.0019.2717.9818.46287K-0.32%
2026-05-1119.3319.8117.6818.52549K-1.28%
2026-05-0818.0819.4618.0018.76242K+4.22%
2026-05-0717.9819.0217.5018.0069K-0.33%
2026-05-0618.2818.5716.7518.06268K-0.11%
2026-05-0518.0518.4316.4318.08149K+0.89%
2026-05-0417.8519.6617.6517.92313K-0.83%
2026-05-0120.7221.4314.8418.07979K-19.22%
2026-04-3020.9023.2320.7222.37274K+6.83%
2026-04-2924.2124.4420.4420.94213K-12.60%
2026-04-2825.1025.1023.7923.9678K-4.73%
2026-04-2724.5526.4324.5425.15145K+1.41%
2026-04-2426.0626.0623.6124.80257K-3.50%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

CBIO — Frequently Asked Questions

Quick answers to the most common questions about buying CBIO stock.

How has CBIO stock performed recently?

CBIO returned +11.4% over the past year, beating its 5-year annualized CAGR of -39.6%. The stock trades above its 200-day moving average, confirming the uptrend.

What is CBIO's all-time high price?

Crescent Biopharma, Inc. reached $2605.00 on 2018-02-15. The 52-week high is $27.41. Current 1-year return of +11.4% places the stock closer to historical peaks.

Where can I download CBIO historical price data?

This page provides CBIO daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2014-2026, downloadable in CSV format.

450 data points · sampled from 3,140